Acumen Pharmaceuticals Inc (ABOS)

$3.65 0.08 (2.14%)

16:00 EDT ABOS Stock Quote Delayed 30 Minutes

ABOS Stock Earnings: Acumen Pharmaceuticals Beats EPS for Q1 2024

By InvestorPlace Earnings May 14, 2024

ABOS stock results show that Acumen Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q4 2023

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 79,239

Day's Range $3.56 - $3.77

52-Week Range $1.81 - $11.31

Dividend & Yield N/A (N/A)

ABOS Stock Predictions, Articles, and Acumen Pharmaceuticals Inc News

From InvestorPlace
From the Web

Why Is Acumen Pharmaceuticals (ABOS) Stock Up 46% Today?

By William White, InvestorPlace Writer Jul 17, 2023

Acumen Pharmaceuticals (ABOS) stock is on the rise Monday after the company released data from a Phase 1 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jul 17, 2023

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jul 11, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday!

Why Is Acumen (ABOS) Stock Up 95% Today?

By William White, InvestorPlace Writer Sep 28, 2022

Acumen Pharmaceuticals (ABOS) stock is rocketing higher on Wednesday but it's not due to any recent news from the company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

MarketBeat Week in Review – 7/17 - 7/21

From MarketBeat Jul 22, 2023

Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks

Acumen Soars on Alzheimer's Study...Street Sees It Doubling

From MarketBeat Jul 19, 2023

Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?

Acumen Pharmaceuticals prices $130M offering (NASDAQ:ABOS)

From Seeking Alpha Jul 19, 2023

Clinical-stage biopharmaceutical company, Acumen Pharmaceuticals (ABOS) prices an upsized underwritten public offering of ~16.77M shares at a price to the public of $7.75 per share

Why Shares of Acumen Pharmaceuticals Are Down Tuesday

From The Motley Fool Jul 18, 2023

The company announced a $100 million stock sale.

Acumen Pharma plans for $100M stock offering, shares fall

From Seeking Alpha Jul 17, 2023

Acumen Pharmaceuticals (ABOS) has proposed an underwritten public offering of its common stock to raise $100 million, the company said Monday. Read more here.

H.C. Wainwright Reaffirms Their Buy Rating on Acumen Pharmaceuticals (ABOS)

From TipRanks Nov 15, 2022

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Acumen Pharmaceuticals (ABOS – Research Report), with a price target o...

ADVERTISEMENT